Harenberg, J <br/><br/>
Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.  [electronic resource] 

 -  Thrombosis and haemostasis  May 2000 
 - 652-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Anticoagulants--administration & dosage<br/>Body Weight<br/>Cohort Studies<br/>Female<br/>Hemorrhage--chemically induced<br/>Heparin--administration & dosage<br/>Heparin, Low-Molecular-Weight--administration & dosage<br/>Humans<br/>Injections, Intravenous<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Phlebography<br/>Popliteal Vein<br/>Postoperative Complications--diagnostic imaging<br/>Recurrence<br/>Treatment Outcome<br/>Venous Thrombosis--diagnostic imaging<br/>Vitamin K--antagonists & inhibitors